Filters close
21-May-1998 12:00 AM EDT
New Non-Toxic Drug for AIDS
American Society for Microbiology (ASM)

A trial of this new treatment for HIV/AIDS suggests that it can stimulate the immune system to produce increased CD4 cells without an accompanying rise in HIV viral load. Patients who received Reticulose also gained weight and their clinical condition improved compared to controls.

21-May-1998 12:00 AM EDT
Study Leads to New Standard of Care for Treating Unstable Angina
Perelman School of Medicine at the University of Pennsylvania

A major international study by cardiologists has shown that the addition of tirofiban into the medical management of patients with unstable angina reduces their risk of death by as much as 47%.

Released: 20-May-1998 12:00 AM EDT
Grant Awarded to Measure How Students Use Computers to Quickly Answer Medical Questions
University of California, Irvine

A few years from now, during a checkup, your physician will turn to a wristband computer and type in a few words. Seconds later, the doctor will have specific answers to questions about a new drug or diagnostic test.

Released: 20-May-1998 12:00 AM EDT
ANA Joins Members of Congress in Push for Legislative Action to Secure Patient Protections
American Nurses Association (ANA)

American Nurses Association leader joins U.S. House of Representatives Health Care Task Force Co-Chairs and Senate leaders to urge the Republican leadership of Congress to stop blocking managed care reform legislation. A key focus of their call to legislative action was the unmet needs of women and children.

21-May-1998 12:00 AM EDT
American Heart Association Comment: Tirofiban -- the platelet receptor blocker for heart attack
American Heart Association (AHA)

Two new studies in the New England Journal of Medicine on tirofiban (Aggrastat) show that the drug may be useful in the treatment of heart attack. "Tirofiban is a novel drug that will open the door to new treatments for the preceding stages of heart attack or the heart attack itself," says Valentin Fuster, M.D., Ph.D., president-elect of the American Heart Association, commenting on two studies.

Released: 20-May-1998 12:00 AM EDT
First Drug in 20 Years Offers New Hope
N/A

For the first time in more than 20 years, a new product is available to combat the deadliest form of skin cancer ñ metastatic melanoma. Proleukin (aldesleukin), a recombinant form of interleukin-2 approved this year by the U.S. Food and Drug Administration (FDA) for the treatment of patients with metastatic melanoma, is the only therapy proven to offer a reasonable chance of survival to those patients diagnosed with advanced-stage melanoma.

Released: 20-May-1998 12:00 AM EDT
Aggrastat is first "platelet blocker" drug approved for treatment of unstable angina
Merck & Company

The U.S. Food and Drug Administration has approved Aggrastat (tirofiban HCl), as the first and only medicine in a class of drugs called glycoprotein (GP) IIb/IIIa inhibitors ("platelet blockers") to reduce the combined risk of death, new heart attack or refractory ischemia*/repeat cardiac procedures in patients presenting with unstable angina or non-Q-wave myocardial infarction, Merck & Co., Inc. announced today.

20-May-1998 12:00 AM EDT
New Test May Reduce Need for Some Prostate Cancer Biopsies
Johns Hopkins Medicine

A new prostate specific antigen (PSA) test that measures the percentage of "free" PSA in the blood not bound to other proteins could spare up to 200,000 men a year in the United States the pain, anxiety and inconvenience of a surgical biopsy to detect cancer.

20-May-1998 12:00 AM EDT
Gene Therapy May Offer New Treatment for Brain Tumors
American Academy of Neurology (AAN)

A gene therapy technique may provide a new treatment for fatal, cancerous brain tumors, according to a study published in the May issue of Neurology, the scientific journal of the American Academy of Neurology.

20-May-1998 12:00 AM EDT
Adding Zinc, Aloe, Grapefruit Extract to Toothpaste Helps Kill Viruses
American Society for Microbiology (ASM)

Over-the-counter toothpaste and mouth rinses may kill bad breath and bacteria, but most are virtually harmless against viruses. Researchers at Pace University have found that by adding naturally occurring substances - such as zinc, aloe and grapefruit extract - to oral hygiene products, they can destroy harmful viruses that lead to illness.

Released: 20-May-1998 12:00 AM EDT
Aggrastat Sidebar
Merck & Company

Protein from African Snake Inspires Development of Aggrastat

Released: 20-May-1998 12:00 AM EDT
Aggrastat Prescribing Information
Merck & Company

Aggrastat (Tirofiban Hydrochloride Injection Premixed) Aggrastat (Tirofiban Hydrochloride Injection)

19-May-1998 12:00 AM EDT
Natural Supplement Prevents Platelet Aggregation
Blitz & Associates

A natural supplement may provide protection from heart attacks or strokes, especially for smokers or those with a family history of heart disease, according to a breakthrough study presented here during the American Society for Biochemistry and Molecular Biology annual meeting.

19-May-1998 12:00 AM EDT
Tea Can Reverse Antibiotic Resistance
American Society for Microbiology (ASM)

Growing methicillin-resistant Staphylococcus aureus in the presence of tea extracts prevents the bacteria from synthesizing an important enzyme for antibiotic resistance, rendering them suceptible to certain antibiotics again.

19-May-1998 12:00 AM EDT
A Two Minute Test for the AIDS Virus Given First U.S. Field Trial in the Bronx
American Society for Microbiology (ASM)

A new test for HIV is extremely simple to carry out and can provide results in a few minutes with an accuracy of nearly 98 percent. A test of this nature could serve as an important screening test in high prevalence areas.

Released: 19-May-1998 12:00 AM EDT
Zeneca Pharmaceuticals, Inc.

New data on CASODEX (bicalutamide) Tablets released here at the 34th Annual Meeting of the American Society of Clinical Oncology offer additional evidence of the medicationís positive clinical benefits, both as monotherapy and in combination with a luteinizing hormone-releasing hormone analogue (LHRH-A), in the treatment of advanced prostate cancer.

Released: 19-May-1998 12:00 AM EDT
Study Suggests bcl-2 Gene as Cause for Aggressive Prostate Cancer in African American Men
UC Davis Health (Defunct)

A gene that blocks cells from dying may play a role in prostate cancer in African Americans, offering a new hypothesis as to why black men have the highest rate of prostate cancer in the world. The findings appear in the June issue of the Journal of Urology.

Released: 19-May-1998 12:00 AM EDT
Genetics Institute Announces Formation of Hemophilia Group
Porter Novelli, New York

Genetics Institute, Inc., a wholly-owned subsidiary of American Home Products, announced today the formation of the Genetics Institute Hemophilia Group, a group within the company dedicated to advancing care for people with hemophilia and their caregivers through advanced technologies and community-based programs.

Released: 19-May-1998 12:00 AM EDT
FDA, EMEA to Review Applications for New Hemophilia A Treatment
Porter Novelli, New York

Genetics Institute and Wyeth-Ayerst announced today that the U.S. Food and Drug Administration and the European Medicines Evaluation Agency (EMEA) have accepted for review a Biologics License Application (BLA) and a Marketing Authorisation Application (MAA) for ReFacto(R) Antihemophilic Factor (Recombinant), an albumin-free formulated recombinant factor VIII product for the treatment of hemophilia A.

Released: 19-May-1998 12:00 AM EDT
Dr. Joycelyn Elders, former Surgeon General speaks at booksigning
University of Arkansas for Medical Sciences

Joycelyn Elders, M.D., spoke about her former position as the United States Surgeon General at a book signing at her alma mater, the University of Arkansas for Medical Sciences.

Released: 19-May-1998 12:00 AM EDT
New Vancomycin Structure May Point to Path for Overcoming Antibiotic Resistance
Perelman School of Medicine at the University of Pennsylvania

In March, a New York man became the first U.S. person to die from infection by a bacteria resistant to vancomycin, the powerful antibiotic physicians turn to when others fail. Now, scientists report discovery of a novel form of vancomycin that advances the search for more effective versions of the antibiotic.

Released: 19-May-1998 12:00 AM EDT
Testosterone levels rise in fans of winning teams
University of Utah

Men who watch their favorite sports team compete and win experience the same type of testosterone surges as the players.

   
Released: 19-May-1998 12:00 AM EDT
Experimental Blood Tests Predicts Heart Disease Risk From New Form of Cholesterol
UT Southwestern Medical Center

Every year millions of people with "normal" cholesterol levels suffer chest pain or heart attacks. A UT Southwestern Medical Center at Dallas study indicates these individuals may suffer from a high concentration of a type of cholesterol not detected with conventional screenings.

Released: 19-May-1998 12:00 AM EDT
Children Exposed to Second-Hand Smoke at Greater Risk During Surgery
American Society of Anesthesiologists (ASA)

Medical researchers have established a link between second-hand tobacco smoke and serious breathing problems for children who receive general anesthesia. Girls are at greater risk, especially those whose mothers have a lower level of education, according to a study published in the May 1998 scientific journal Anesthesiology, the scientific publication of the American Society of Anesthesiologists.

20-May-1998 12:00 AM EDT
FDA Approves Prometrium (Progesterone, USP) Capsules
Fleishman-Hillard, New York

U.S. Food and Drug Administration Approves Prometrium (Progesterone, USP) Capsules, Only Oral Form of Micronized Progesterone

18-May-1998 12:00 AM EDT
Teens with High Blood Pressure May Have Enlarged Hearts
American Heart Association (AHA)

Teenagers, especially boys, with high blood pressure may be harboring a serious, but silent, heart condition, according to two new studies and an editorial in today's Circulation: Journal of the American Heart Association.

18-May-1998 12:00 AM EDT
Food Preservatives May Help Prevent Dental Caries
American Society for Microbiology (ASM)

Weak acids and parabens, common food preservatives, may actually help prevent certain types of plaque and gum disease.

18-May-1998 12:00 AM EDT
Aspirin Helps in Infective Endocarditis
American Society for Microbiology (ASM)

In addition to preventing future heart attacks, aspirin can help reduce the damage caused by endocarditis, a bacterial infection of the inner lining of the heart.

18-May-1998 12:00 AM EDT
Tropical Plants: Potential Source for Antibiotics
American Society for Microbiology (ASM)

A screening of extracts from tropical plants uncovers ten compounds that have potneital to produce antituberculosis drugs.

Released: 16-May-1998 12:00 AM EDT
IAVI Highlights Gaps in Current AIDS Vaccine Development Efforts
InterScience Communications

International AIDS Vaccine Initiative president Dr. Seth Berkley issued the following statement to mark the first anniversary of President Clinton's May 18, 1997 call to develop an AIDS vaccine within a decade.

Released: 16-May-1998 12:00 AM EDT
106th Annual Convention of the American Psychological Association
American Psychological Association (APA)

Psychology's movement away from an exclusive focus on assessing and repairing illness and toward an emphasis on prevention will be an overarching theme of the 106th Annual Convention of the American Psychological Association.

   
Released: 16-May-1998 12:00 AM EDT
Second Annual Invitational Seminar on Macular Degeneration
Lighthouse International

Innovations in research, diagnosis and treatment of macular degeneration will be the topic of The Lighthouse Inc. Second Annual Invitational Symposium to be held on Friday, June 12, 1998. Key medical issues will be covered along with examination of the trends in vision rehabiliation research, practice and therapy.

Released: 15-May-1998 12:00 AM EDT
Gay and Lesbian Issues Featured At APA Annual Meeting
American Psychiatric Association (APA)

Tips: 1- Gay Men, Lesbians, and Bisexuals: Controversial Issues 2- Interpersonal Psychotherapy for the Treatment of Depression in HIV-Positive Men and Women 3- Pathology to Pride: Evolving Views of Homosexuality

Released: 15-May-1998 12:00 AM EDT
Aviron's Flumist Vaccine 93% Effective Against Influenza
Fleishman-Hillard, New York

A study published in today's issue of the New England Journal of Medicine found Aviron's FluMist, intranasal influenza virus vaccine, provided 93 percent protection against culture-confirmed influenza and also provided 98 percent protection against influenza-associated ear infections.

Released: 15-May-1998 12:00 AM EDT
Compound in Meat Prevents Diabetes
Purdue University

A common type of fat found in red meats and cheeses may prevent diabetes, according to a research team from Purdue University and The Pennsylvania State University. This information could lead to new drugs to help fight diabetes, or to improved dietary strategies to manage diabetes, the researchers say.

Released: 15-May-1998 12:00 AM EDT
Nasal Spray Vaccine Prevents Flu and Ear Infections
Saint Louis University Medical Center

In the May 14 edition of the New England Journal of Medicine, a nasal spray flu vaccine effectively prevents the flu in children. In addition, to the surprise of scientists involved in the study, the vaccine has also proven highly effective at preventing ear infections.

15-May-1998 12:00 AM EDT
TipSheet from the May 15 Annals of Internal Medicine
American College of Physicians (ACP)

1. New studies of osteoporosis find protein supplements improve patient outcomes; 2. Physicians must address geographic variations in health care; 3. Internists are the doctors best trained to provide continuity of care.

Released: 14-May-1998 12:00 AM EDT
Tobacco Revelations on Internet
New Scientist

Astonishing documents posted on the Internet reveal that the American tobacco giant Philip Morris secretly recruited influential people to help allay fears about the health risks of passive smoking.

Released: 14-May-1998 12:00 AM EDT
Drug Improves Involuntary Muscle Movements & Motor Fluctuations in Parkinson's Patients
American Academy of Neurology (AAN)

The generic drug amantadine can improve motor fluctuations and dyskinesias (jerky or fragmented involuntary muscle movements) that occur after long-term use of Parkinson's medications, according to a study published in the May issue of Neurology, the scientific journal of the American Academy of Neurology.

14-May-1998 12:00 AM EDT
"Noisy" Ventilators are Better Ventilators
Boston University

In this week's edition of Nature, scientists at Boston University's Department of Biomedical Engineering report a new model of ventilator assisted lung function. In this model the pressure of the air delivered by the ventilator is varied by the addition of noise.

Released: 14-May-1998 12:00 AM EDT
Novartis Therapy to Prevent Acute Rejection in Renal Transplants Cleared for Marketing
Porter Novelli, New York

Novartis Pharmaceuticals Corporation announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Simulect (basiliximab) for prevention of acute rejection episodes in renal transplant recipients.

Released: 14-May-1998 12:00 AM EDT
Communication between Doctors and Asthma Patients Is Key
University of Michigan

Good communication between patient and doctor is as important to staying out of the hospital as getting the right asthma medicine, a new study by a University of Michigan research shows.

13-May-1998 12:00 AM EDT
Researchers Identify a Gene that Causes Juvenile Polyposis
University of Iowa

A gene causing familial juvenile polyposis (FJP), a disorder that causes the growth of polyps in the colon or upper gastrointestinal tract, has been identified by a University of Iowa-led international research team.

7-May-1998 12:00 AM EDT
Gene detected that decreases "bad" LDL cholesterol in men may cut heart disease risk by 50 percent
American Heart Association (AHA)

A gene that helps keep bad cholesterol at bay -- and may reduce heart disease risk by 50 percent -- has been discovered by researchers reporting in this month's Arteriosclerosis, Thombosis and Vascular Biology: Journal of the American Heart Association.

Released: 13-May-1998 12:00 AM EDT
Fetal Lead Exposure May Reduce Immunity
Cornell University

Lead in the drinking water of pregnant rats causes long-term damage to the immune systems of their offspring, according to studies in the Cornell University Institute for Comparative and Environmental Toxicology. The finding in rats -- if it holds true for pregnant human mothers exposed to lead -- could help explain the beginnings of a lifelong susceptibility to asthma and other allergies, as well as cancers.

Released: 13-May-1998 12:00 AM EDT
New Mechanism in Immune Response to HIV Infection Identified by Researchers
University of California San Diego

For the first time, a specific pathway for the launch of a counterattack against HIV, with cells called macrophages stimulated by CD40L to produce proteins which bolster T lymphocytes ("T cells"), scientists from the University of California, San Diego and the Veterans Affairs Medical Center reported recently in the Proceedings of the National Academy of Sciences (April 1998).

13-May-1998 12:00 AM EDT
Oxygen Therapy May Help Minimize Damage from Strokes
Atrium Health Wake Forest Baptist

A small-scale study suggests that hyperbaric oxygen therapy may hasten recovery from stroke and save millions or even billions of dollars annually in health care costs, a medical researcher says. The study also indicates that the new approach could give doctors a vital fourth hour to intervene after the onset of stroke. Current approaches are limited to about three hours

13-May-1998 12:00 AM EDT
A "Small Decline" In Brain Function Could Be Significant Wake Forest Researcher Says
Atrium Health Wake Forest Baptist

While coronary artery bypass surgery routinely saves lives by bypassing clogged arteries, many patients have a 20 percent decline in motor function and other evidence of brain damage following surgery, a Wake Forest University Baptist Medical Center neuropsychologist said today.

Released: 12-May-1998 12:00 AM EDT
UCLA Heart Transplant Program Announces Agreement
University of California, Los Angeles (UCLA), Health Sciences

UCLA Medical Center's Heart Transplant Program announced on May 5 that it has reached a collaborative agreement to begin training its surgeons and staff to install a battery-powered artificial heart replacement device developed and manufactured by ABIOMED, Inc.

Released: 12-May-1998 12:00 AM EDT
HIV Discriminates Amongst Cells
Johns Hopkins Medicine

Researchers at Johns Hopkins have discovered that the human immunodeficiency virus (HIV) depends on the moving parts of a cell's surface to allow it to enter the cell.



close
6.25952